Tag: GSK
GSK: the virus against shingles effective for more than 10 years
(CercleFinance.com) – GSK unveiled new clinical data on Tuesday showing that its shingles vaccine Shingrix retained its effectiveness for more than ten years in patients aged over 50. According to…
GSK: positive clinical results in gonorrhea
(CercleFinance.com) – GSK announced on Wednesday positive results from a phase III clinical study for its new oral antibiotic against gonorrhea, a sexually transmitted infection increasingly resistant to existing treatments.…
Spie: Develops a new production line for GSK
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
GSK: Positive results in the treatment of gonorrhea
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
GSK: finalized the acquisition of Aiolos Bio
(CercleFinance.com) – GSK announced today that it has completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on meeting the unmet therapeutic needs of patients with respiratory and…
GSK: study of a new indication for Shingrix in China
(CercleFinance.com) – GSK announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has agreed to review the regulatory application of Shingrix (recombinant…
CureVac reports promising results from COVID-19 vaccine trials conducted in collaboration with GSK
© Reuters. FRANKFURT – CureVac recently reported encouraging results from its latest COVID-19 vaccine trials, conducted in partnership with GSK. Preliminary data indicate that the vaccines, comprising a monovalent and…
GSK: stock on the rise, a broker raises its advice
(CercleFinance.com) – GSK gains more than 2% in London, helped by an analysis from Jefferies which announced on Wednesday that it had raised its recommendation on the stock from ‘hold’…
GSK: Jefferies raises its recommendation to purchase
(CercleFinance.com) – Jefferies announced on Wednesday that it had raised its recommendation on GSK shares from ‘hold’ to ‘buy’, with a target price raised to 1900 from 1550 pence so…
GSK: EU approves Jemperli in endometrial cancer
(CercleFinance.com) – GSK announced Monday that the European Commission had approved the marketing of its immunotherapy Jemperli in the first-line treatment of endometrial cancer. In a press release, the British…
GSK: encouraging results in multiple myeloma
(CercleFinance.com) – GSK today announced positive results from an interim efficacy analysis of a phase III trial evaluating belantamab mafodotine as a second-line treatment for relapsed or refractory multiple myeloma.…
GSK: Favorable opinion in myelofibrosis with anemia
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…